London, UK – Longfellow Real Estate Partners is making a significant move into the UK market, announcing a landmark joint venture poised to reshape the landscape of life science real estate. In a strategic alliance with the Public Sector Pension Investment Board (PSP Investments) and Norges Bank Investment Management (NBIM), Longfellow Partners is set to invest £1.5 billion into innovative real estate solutions across the United Kingdom, with a laser focus on the prestigious Golden Triangle.
The Golden Triangle, encompassing Cambridge, Oxford, and London, stands as a global epicenter for life sciences and technological advancement. Renowned for its world-class universities, cutting-edge research institutions, and leading teaching hospitals, the region attracts top-tier talent and substantial investment capital. This concentration of resources fosters a dynamic environment for groundbreaking start-ups, rapidly growing companies, and established blue-chip corporations, making it the ideal location for this ambitious venture led by Longfellow Partners.
The initial phase of this partnership sees NBIM joining Longfellow Partners and PSP Investments in the ownership of Capital Park Cambridge. Acquired in May 2022, this expansive 42-acre campus in Cambridge already boasts approximately 245,000 square feet of state-of-the-art workspace. Capital Park Cambridge is currently home to a diverse portfolio of innovative companies spanning sectors from fintech and agtech to biotech, patent law, and the NHS. Cambridge itself is recognized as the UK’s most mature life science real estate market, characterized by its research excellence, skilled workforce, collaborative culture, and sophisticated investment infrastructure. This vibrant ecosystem fuels industry-academic-clinical partnerships and propels continuous innovation, perfectly aligning with the vision of Longfellow Partners.
“This joint venture with Norges Bank Investment Management and PSP Investments underscores the strength and focused approach of Longfellow’s life science real estate platform,” stated Adam Sichol, Co-Founder & CEO of Longfellow Real Estate Partners. “Together, we recognize a unique opportunity to develop exceptional, world-class spaces that will support a wide spectrum of tenants within the UK’s thriving life science and innovation ecosystems.”
Jayesh Patel, Head of UK Real Estate at Norges Bank Investment Management, expressed enthusiasm for the collaboration, stating, “We anticipate a productive long-term partnership with Longfellow and PSP Investments in the strategically important UK life science sector.”
Stéphane Jalbert, Managing Director, Head of Asia-Pacific and Europe, Real Estate Investments, PSP Investments, added, “We are delighted to welcome NBIM to this life sciences partnership with Longfellow. This venture provides us with the scale to invest meaningfully in the rapidly evolving life science sector, fostering environments where corporations, universities, and start-ups converge, facilitating knowledge exchange and accelerating innovation.”
About Longfellow Real Estate Partners
Founded in Boston, Massachusetts in 2009, Longfellow Real Estate Partners is a leading real estate investment firm dedicated to supporting the life science and technology sectors. With a growing team of over 200 professionals operating within key bio-innovation clusters across the US and UK, Longfellow Partners collaborates with prestigious universities and pioneering companies. Their mission is driven by a passion to empower those at the forefront of scientific advancement, providing the specialized real estate environments necessary to translate visionary ideas into tangible realities. Longfellow Partners continues to expand its reach, committed to fueling progress in the life sciences and beyond. For further details, please visit https://lfrep.com.
This strategic joint venture marks a pivotal moment for Longfellow Partners as they extend their expertise and investment philosophy to the UK. By focusing on the Golden Triangle and committing significant capital, Longfellow Partners, alongside PSP Investments and NBIM, are poised to become key players in shaping the future of UK life science real estate, fostering innovation and driving growth within this critical sector.
